Stephan Georg MUELLER

8-AZA QUINAZOLINES AS BRAIN-PENETRANT SOS1-INHIBITORS

Novel bicyclic benzylamido pyridine derivatives as SOS1 inhibitors

HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF CANCER

2-[thiophen-2-yl)formamido]-N-(phenyl)-2-methylpropanamide derivatives and the use thereof as medicament

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

(Cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them

NOVEL COMPOUNDS

Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors

CGRP antagonists

Substituted piperazines as CGRP antagonists

6,7,8,9-Tetrahydro-5H-1,4,7,10a-tetraaza-cyclohept[f]indene derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them

NOUVEL COMPOUNDS

Pyrimidine derivatives which are CGRP—antagonists

NEW PYRIDONE DERIVATES WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS

Compounds

CGRP antagonists

CGRP ANTAGONISTS

SELECTED CGRP ANTAGONISTS, PROCESSES FOR PREPARING THEM AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS

Compounds

Compounds

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Pyridazine Derivatives with MCH Antagonistic Activity and Medicaments Comprising These Compounds

CGRP Antagonists

New CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, processes for preparing them and their use as pharmaceutical compositions

CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Selected Cgrp-Antagonists, Processes for Preparing Them and Their Use as Pharmaceutical Compositions

Pyridone derivates with MCH antagonistic activity and medicaments comprising these compounds

Use of selected CGRP antagonists for combating menopausal hot flushes

CGRP Antagonists

CGRP antagonists

Use of selected CGRP-antagonists in combination with other antimigraine drugs for the treatment of migraine

Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Use of selected CGRP antagonists in treatment and prevention of hot flushes in prostate cancer patients

CGRP antagonists

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

New (hetero)aryl compounds with MCH antagonistic activity and medicaments comprising these compounds

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Beta-agonists, processes for preparing them and their use as pharmaceutical compositions

Use of CGRP antagonists in treatment and prevention of hot flushes in prostate cancer patients

Use of selected CGRP antagonists for combating menopausal hot flushes

Use of selected CGRP-antagonists in combination with other antimigraine drugs for the treatment of migraine

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Amide compounds with MCH antagonistic activity and medicaments comprising these compounds

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

β-ketoamide compounds with MCH antagonistic activity

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Selected CGRP—antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions

Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof

Substituted piperidines, medicaments containing these compounds, and methods for the production thereof